IMM-BCP-01 in Mild to Moderate COVID-19
Clinical trial NCT05429021 · TERMINATED
Trial details
- NCT number
- NCT05429021
- Sponsor
- Immunome, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-03
- Primary completion
- 2023-01-06
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.